FDA has requested that NCPA members voluntarily provide them with information on the OTC drug shortages they face. FDA is particularly interested in these OTC products: ibuprofen children’s suspension, pediatric drops, and chewable tablets, and acetaminophen children’s suspension and pediatric drops. FDA’s specific questions to members are:
-
What percentage of your order are you receiving for each of these products weekly?
-
Is there a demand that you are unable to fill for each of these products?
If you are willing to provide data to FDA, please send it to: [email protected], and cc Steve Postal at NCPA at [email protected].
NCPA
